Related Experiment Video
Updated: Jun 12, 2025

Assessment of Dependence in Activities of Daily Living Among Older Patients in an Acute Care Unit
Published on: September 30, 2020
Adverse Drug Events in Ambulatory Care: A Cross-Sectional Study
Joseph M Plasek1,2,3, Mary G Amato4,5, Abigail Salem4,5,6
1Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital, Boston, MA, USA. jplasek@mgb.org.
Adverse drug events (ADEs) occurred in 44.2% of outpatient encounters, with anti-infectives and CNS agents being common causes. This research enhances pharmacovigilance by detailing ADE prevalence and characteristics in ambulatory care.
Area of Science:
- Pharmacovigilance
- Health Informatics
- Clinical Pharmacology
Background:
- Adverse drug events (ADEs) are significantly understudied in ambulatory care settings.
- Electronic Health Records (EHRs) offer a valuable resource for investigating ADEs in outpatient populations.
- Understanding ADE prevalence is crucial for improving patient safety in non-hospital settings.
Purpose of the Study:
- To estimate the prevalence and characterize Adverse Drug Events (ADEs) in the outpatient setting.
- To leverage Electronic Health Records (EHRs) for comprehensive ADE analysis.
- To inform pharmacovigilance strategies for ambulatory care.
Main Methods:
- A cross-sectional study utilizing EHR data from an academic medical center (October 2018 - December 2019).
- A stratified sampling strategy using 994 International Classification of Disease (ICD-10) codes related to ADEs.
- Random sampling and annotation of clinical notes to identify ADEs, their causal agents, and severity.
Main Results:
- Out of 3126 analyzed notes, 44.2% documented present or possible ADEs, totaling 6308 mentions.
- Hypersensitivity reactions (14.1%) and significant ADEs (60.4%) were most common.
- Estimated prevalence was 1.97 per 100 encounters (2.52 per 100 including possible ADEs), with anti-infectives and CNS agents as primary causal agents.
Conclusions:
- This study quantifies ADE prevalence in outpatient settings using ICD-10 codes and clinical notes.
- Findings advance pharmacovigilance by detailing ADE characteristics in ambulatory care.
- Improved detection, monitoring, and prevention of ADEs in outpatient settings are facilitated by this research.
More Related Videos
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Errors occurring during blood pressure monitoring
Several factors...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...

